Introduction: The spinal cord is poorly visualized on CT images but is well visualized
CT scans. Spinal cord can be accurately contoured on the registered MR images. However, if implants are used for spinal stabilization it can produce artifacts on the MRI images which can interfere with identification of the cord accurately. 1, 2 Sometimes the tumors involving the vertebral bodies per se also hinder identification of the cord.
It is of paramount importance to identify the cord accurately and limit the dose to the cord, since excessive dose to the spinal cord is associated with irreversible myelopathy. 3 CT myelography is a technique which is used to identify abnormalities in the spinal cord in cases where MRI is contraindicated. We decided to do a CT myelogram in conjunction with CT simulation in a patient with vertebral hemangioma and we report the differences in the pre and post myelogram planning parameters to highlight the advantage of combining this technique.
| MATERIALS AND METHODS
The patient was immobilized using a Vac-Lok [manufacturer -Klarity medicals] in the supine position. CT simulation was taken using CT Somatom Spirit a dedicated CT machine for simulation. CT was acquired from T6 to L5. Our CT scanner does not have a metal artifact reduction algorithm.
Images acquired from CT had a slice thickness of 3 mm and the reconstructed image from the Eclipse registration software was also 3 mm. After premedication a lumbar puncture was done, dye was injected into the spinal canal and the patient was immobilized using the same Vac-Lok. The neurosurgeon performed the lumbar puncture and injection. No additional staff was required for the simulation. The normal CT simulation consent form was modified to inform the patient about any potential risks of CT myelography.
Premedications for myelogram and post myelogram instructions were given. However, the procedure of CT simulation remained the same.
A second set of simulation images were taken using the same parameters. Two volumes were contoured -Gross tumor volume and Planning target volumes. Spinal cord, kidneys, lungs, stomach and intestines were the organs at risk. Contouring was done separately for each CT image. The tumor in both the instances was drawn based on the registered MRI images. However in Plain CT images, the area of the tumor drawn was an approximation since the cord was not seen due to the susceptibility artifacts in the fused MR images. However in the post myelogram CT images, the tumor edges could be drawn clearly where it was seen distinct from areas occupied by the contrast in the spinal canal and the cord. This led to a reduction in the PTV volume by almost 20 cc.
The spinal cord is suspended in the CSF and is tethered by roots and the dentate ligament. Hence it is unlikely to move significantly in the spinal canal on a day to day basis. However, small movements were accounted for by giving a small margin around the spinal cord of 3 mm. We gave a margin of 3 mm around the cord to create the PRV cord [planning organ at risk volume].
Plans were generated on pre-and post myelography CT images using Eclipse TM treatment planning system (TPS) version 10.0, Varian Medical Systems, USA. The TPS used analytical anisotropic algorithm (AAA) algorithm for calculation of monitor units and progressive resolution optimizer (PRO) version 10 for VMAT plans. Since the contouring was done separately for each CT image and there was a difference in the PTV volume between the two images, separate plans had to be created for the pre and post myelogram images.
During planning, the contrast around the cord had a Hounsfield unit (HU) of 200-350 HU. We have assigned HU manually for the contrast. Since the spinal canal contains CSF and during the actual treatment it is the CSF which fills the spinal canal, we assigned tissue equivalent value for the contrast which is zero HU.
The prescribed total dose to PTV was 40 Gy in 20 fractions and the optimization constraint was that 95% isodose line encompasses 95% of PTV. The optimization constraint given for the spinal cord was that the D-Max dose to any part of the spinal cord was kept below 40 Gy and both the plans met the specified objectives.
The Varian Clinac iX with 6 MV photon energy was used for delivering the treatment.
| RESULTS
The cord was poorly visualized in the premyelogram CT images. The titanium implants used for spinal cord stabilization produced artifacts in the MRI images. We have also applied the same plan done on the premyelogram CT to the post myelogram CT.
The only complication which was reported was headache which developed 24 hr after the procedure. Headache lasted for 1 day and subsided with adequate hydration, paracetamol and foot end elevation.
| DISCUSSION
Radiation damage to the spinal cord is one of the most dreaded complications in the treatment of cancer. 4 Very often, dose to the tumor is compromised to avoid overdosing the cord. spinal canal volume as a surrogate for the cord. Registration with MRI and contouring the cord on the registered MRI is often the solution. However, this has its own errors especially due to the artifacts caused by the implants used for spinal stabilization. Titanium implants can cause distortion of the image or even obscure surrounding anatomy around them due to susceptibility artifacts. Figure 1 In such cases, we suggest that identification of the cord is done by CT myelogram.
In our patient, the cord was poorly visualized in the plain CT images. We could not reliably contour the cord using the registered MR images because of the severe distortion caused by the implants. Similarly, the PRV cord volume also decreased from 5.4 to 1 cc.
The mean dose received by the PTV and PRV cord overlap increased from 70.8% to 92%.
It is clear from our data that the dose to the overlap region was more in the post myelogram CT which indicates that this area which can potentially harbor tumor tissue could receive a higher dose.
Thus, CT myelogram helped us to increase the dose to the PTV and decrease the dose to the spinal cord.
Thariat et al. studied the value of CT myelography in the delineation of the spinal cord and found that CT myelography had superior resolution to MRI when Cyber knife stereotactic radiotherapy was used. 6 We compared the premyelogram and post myelogram plans in our patient where susceptibility artifacts were prominent.
An important finding in our study was that dose to the overlap region [PTV and PRV cord] was more in the post myelogram CT, which indicates that this area which can potentially harbor tumor tissue could receive a higher dose.
As far as we know this is the first description of the use of CT myelogram to achieve dose optimization in radiation therapy of vertebral hemangioma in cases where spinal implants have been used.
We wanted to describe a simple method which will identify the cord accurately which is applicable in cases such as this where titanium implants obscured the normal anatomy. Since we could identify the cord clearly we could reduce the radiation dose well below the recommended tolerance dose of 40 Gy while keeping an optimal PTV dose. Even the recommended tolerance dose of 40-44 Gy to spinal cord has a 5 yr probability of complications of 5%. By staying below this dose, we reduce even this small probability of complication and such a strategy may reduce the risks of myelopathy in case the patient requires re-irradiation in the future. An important finding in our study was that dose to the overlap region was more in the post myelogram CT, which indicates that this area which can potentially harbor tumor tissue could receive a higher dose. Thus, CT myelogram not only helped us to decrease the dose to the spinal cord but also to increase the dose to the PTV.
However, myelogram is contraindicated if there is a spinal block or if the cord is low lying. One should also be absolutely certain that only non-ionic contrast is used since inadvertent intrathecal injection of ionic contrast media is fatal. 
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